Similar articles

• Low renin hypertension (LRH): shades of John Laragh.

  Funder J, New MI. Funder J, et al. Trends Endocrinol Metab. 2008 Apr;19(3):83. doi: 10.1016/j.tem.2008.01.008. Epub 2008 Mar 18. Trends Endocrinol Metab. 2008. PMID: 18353670 No abstract available.
• Aldosteronism and hypertension.

  Calhoun DA. Calhoun DA. Clin J Am Soc Nephrol. 2006 Sep;1(5):1039-45. doi: 10.2215/CJN.01060306. Epub 2006 Jul 12. Clin J Am Soc Nephrol. 2006. PMID: 17699324 Review.
• [Is there an unrecognized epidemic of primary aldosteronism? The Danish Society of Hypertension].

  Shahmarvand N, Poulsen PL, Ibsen H; Dansk Hypertensionsselskab. Shahmarvand N, et al. Ugeskr Laeger. 2008 Mar 17;170(12):1030. Ugeskr Laeger. 2008. PMID: 18397648 Danish. No abstract available.
• Optimal use and interpretation of the aldosterone renin ratio to detect aldosterone excess in hypertension.

  Doi SA, Abalkhail S, Al-Qudhaiby MM, Al-Humood K, Hafez MF, Al-Shoumer KA. Doi SA, et al. J Hum Hypertens. 2006 Jul;20(7):482-9. doi: 10.1038/sj.jhh.1002024. Epub 2006 Apr 13. J Hum Hypertens. 2006. PMID: 16617310 Review.
• Dynamic aldosterone and 18-hydroxydeoxycorticosterone studies in labile and stable benign essential hypertension.

  Nowaczynski W, Kuchel O, Genest J, Messerli FH, Honda M, Tolis G, Seth K, Parvin-Pande R, Kubo S, Grose J, Ledoux F, Lebel M. Nowaczynski W, et al. J Steroid Biochem. 1975 May;6(5):767-78. doi: 10.1016/0022-4731(75)90066-7. J Steroid Biochem. 1975. PMID: 171513 No abstract available.